Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANI PHARMACEUTICALS INC Director's Dealing 2014

Apr 4, 2014

31676_dirs_2014-04-04_02a421af-b721-4094-a859-a71552503c8b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2014-04-01

Reporting Person: Penn Thomas A. (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-04-01 Option to Purchase $33.00 A 2500 Acquired 2024-03-31 Common Stock (2500) Direct

Footnotes

F1: 833 options vest on April 1, 2015, 833 options vest on April 1, 2016, and 834 options vest on April 1, 2017.